Eil Lilly announces Zepbound to be sold directly to consumers

(4:4)

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

(7:14)

David A Ricks, Chair and Chief Executive Officer of Eli Lilly and Company

(45:30)

Why Only 3 Pharmaceutical Companies Make Insulin

(29:42)

Eli Lilly's drop after earnings is a buying opportunity, says Mizuho's Jared Holz

(5:27)

VW - Einigung im Tarifstreit bringt keine Erleichterung, Rheinmetall und Nvidia im Fokus

(1:2:18)

Novo Nordisk Aktie implodiert nach Studie, keine Chance in Zukunft gegen Eli Lilly?

(9:29)

Novo Nordisk : La CHUTE LIBRE ! (Et Eli Lilly se frotte les mains...)

(19:51)

Eli Lilly Expands Zepbound Access! – What’s the Catch?

(8:38)

ELI LILLY: Alarming suspicion! Has the pharmaceutical giant influenced German legislation?

(6:43)

Novo's Weight Loss Drug Disappoints; Stock Falls Most on Record

(6:40)

Warren E. Buffett, 25th Anniversary of The Economic Club of Washington, D.C.

(43:24)

The David Rubenstein Show: Carla Hayden

(24:6)

LLY's Zepbound to Treat Sleep Apnea, QCOM Tops ARM in Court, Honda/Nissan Merger Talks

(8:1econd)

Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage

(4:49)

Eli Lilly's miss explanation is 'totally opaque', says Jim Cramer

(9:35)

Eli Lilly CEO: We have 11 pipeline projects in obesity

(2:22)

Exclusive: How Eli Lilly’s making weight loss drugs more accessible

(7:4)

Eli Lilly to sell Zepbound directly to consumers without insurance

(3:)

Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024

(2:1econd)

Eli Lilly warns about fake weight loss drugs

(2:4)

Coach Declares the BMS Team is Now Celibate | Blue Mountain State

(4:37)

This is NVIDIA’s new GPU - Blackwell NVL72 Rack

(12:58)

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

(3:11)

Eli Lilly's Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita Patel

(6:)

Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro

(2:59)

Eli Lilly's Drug Reduces Diabetes Risk by 94% for Pre-Diabetic, Obese Patients

(30)

Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vials

(5:29)

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

(1:41)

Eli Lilly’s Affordable Weight Loss Breakthrough

(36)